Abi Carter is timing the partnership with the release of her upcoming album.
American Idol’s 2024 winner is teaming up with Inland Empire Health Plan (IEHP) to promote mental health awareness.1 Abi Carter, an Indio, California, native, is timing the partnership with the release of her first album on November 15. The campaign will be focused on promoting wellness check-ins for young people.
In a press release, IEHP chief executive officer Jarrod McNaughton said, “Besides being a talented musician, Abi has a passion for wellness. Her social media messages about healing, self-care and community, in addition to her strong connection to young audiences, make her the perfect partner to promote these important discussions."
Carter added, “Growing up in Indio as a former member of IEHP, I've seen firsthand the need for greater mental health support, especially for young people. I'm honored to partner with IEHP to spread awareness and help open the conversation around mental wellness."
IEHP is also involved in other charitable activities. In October, the organization announced that it had raised $25,000 for breast cancer research as part of its More Than Pink Walk.2
In a press release issued at the time, IEHP’s chief operating officer Susie White said, “Coming together as an organization to walk reminds me of the family, friends and community who are impacted by breast cancer. I walk for my mom and to remind others that they are not alone in their journey. Together, we can make a lasting impact one step at a time."
Jill Eaton, executive director of the nonprofit's Inland Empire and Nevada region, added, “We are honored to have IEHP, the 2024 Pilar sponsor for the Susan G. Komen Inland Empire MORE THAN PINK walk, [on board]. Together we are making a profound impact in the fight against breast cancer. Supporting individuals in our community who are facing breast cancer is essential to our mission, and we do not do this alone."
"Participation in 'Team IEHP Goes Pink' grows every year, and the generosity of our team never ceases to amaze me," said Rebecca Mayer, director of operations administration for IEHP. "I'm lucky to work for an organization where everyone believes in opening access to optimal care."
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.